Our Speakers

Dr. Alfred V.Krempelhuber


Medical Director Germany

Transformation in the role of Medical Affairs following the COVID-19 Pandemic

The COVID-9 pandemic changed the contact patterns and roles internally and externally.

  • How did this change the relationship to colleagues and external stakeholders?
  • What will change back and what will stay after the pandemic?
  • What are the most successful communication strategies?
Dr. Alfred V.Krempelhuber Photo Moderna Logo

Sara Korchmaros


Global Lead for Data and Analytics, Oncology

Understanding the practical application of technologies such as AL, NLP, ML for Medical Affairs

  • Using Artificial Intelligence, machine learning, block-chain and algorithms to uncover disease state opportunities, accelerate and synthesize insights from real world data
  • Embracing the power of data and analytics, as well as digital-engagement techniques to maximise patient experience and outcomes
  • Using analytics to collect metrics, apply learnings and develop tools for cross-functional use
Sara Korchmaros Photo AstraZeneca Logo

Natasha Hansjee Altmann

Hoffmann La-Roche

Principal Scientific Communications Director

Tackling Today's Challenges in Medical Education

  • Overview of the scientific exchange evolution
  • What do HCPs want?
  • Where do we go from here?
Natasha Hansjee Altmann Photo Hoffmann La-Roche Logo

Dr Bishember Kathuria


Global Lead - Digital Transformation, Medical Affairs

Simplification and Standardization: Key to Digital Transformation

  • Why majority of digital transformations fail ?
  • There is an app for that but do we need it ?
  • Simplified and Standardized processes versus new technology
  • Take control of digital transformation in medical
Dr Bishember Kathuria Photo Novartis Logo

Zsuzsanna Devecseri


VP Global Oncology Medical Head

Patient-centric Medical Affairs

  • What patient centric outcomes are and how to measure them?
  • Changing role of patient in treatment decision making.
  • Evolution of the delivery of care and its drivers.
  • How to work with effectively with patients/advocacy groups?
Zsuzsanna Devecseri Photo Sanofi Logo
As innovation transforms the healthcare sector, science and data are becoming the foundation for pharma to meet its commitments to patients and customers while also realizing commercial opportunities. This imperative is accelerating the emergence of medical affairs as the organization's third strategic pillar, alongside R&D and commercial. Hence, Pronovea is bringing together pharma pioneers and healthcare innovators to discuss and exchange best practices and strategic insights; collaborate to enhance communication strategies; build-out medical affairs teams; get ready for launches; explore various tools to track progress, and keep customers engaged in a digital world.